Brief: Chong Kun Dang Pharmaceutical receives patent

Chong Kun Dang Pharmaceutical

04/11/2016 05:10

Nov 4 (Reuters) - Chong Kun Dang Pharmaceutical Corp 
 185750.KS  : 
 
    * Says it receives Europe patent on Nov. 4, for methods for 
purifying erythropoietin analogs having lower isoelectric point 
    * Patent application number is 2841143.6 
     
     
    Source text in Korean: https://goo.gl/vxgjME 
    Further company coverage:  185750.KS  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: hedy.cui.reuters.com@reuters.net))